Matches in Wikidata for { <http://www.wikidata.org/entity/Q80242335> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q80242335 description "2006 թվականի սեպտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q80242335 description "article scientifique publié en 2006" @default.
- Q80242335 description "artículu científicu espublizáu en setiembre de 2006" @default.
- Q80242335 description "im September 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80242335 description "scientific article published on 11 September 2006" @default.
- Q80242335 description "wetenschappelijk artikel" @default.
- Q80242335 description "наукова стаття, опублікована у вересні 2006" @default.
- Q80242335 name "Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer" @default.
- Q80242335 name "Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer" @default.
- Q80242335 type Item @default.
- Q80242335 label "Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer" @default.
- Q80242335 label "Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer" @default.
- Q80242335 prefLabel "Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer" @default.
- Q80242335 prefLabel "Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer" @default.
- Q80242335 P1433 Q80242335-4DA6FA97-29CC-4CD8-9DAB-717037540B98 @default.
- Q80242335 P1476 Q80242335-216ECD03-BF5F-4C6C-BFD7-A9E08962E738 @default.
- Q80242335 P2093 Q80242335-2FA39209-905E-4B68-B2B2-0C77605BD117 @default.
- Q80242335 P2093 Q80242335-376D8AEB-447E-49FE-A2FD-8B8C3B8819DF @default.
- Q80242335 P2093 Q80242335-46A5DD8F-28AF-4F10-B96A-3C7086AA287A @default.
- Q80242335 P2093 Q80242335-4ABCEC16-1324-412B-8520-A0164B8E8F56 @default.
- Q80242335 P2093 Q80242335-634C9D91-F004-45B3-8F5E-8A4B05801206 @default.
- Q80242335 P2093 Q80242335-66BB760B-25AA-4010-8704-85050B498394 @default.
- Q80242335 P2093 Q80242335-763214EA-447C-4E52-9E62-28924E750498 @default.
- Q80242335 P2093 Q80242335-7F17F0A1-3F11-426D-8121-2149012F5E6C @default.
- Q80242335 P2093 Q80242335-A3B70B9D-564B-4DFE-9413-0D6F5E67448F @default.
- Q80242335 P2093 Q80242335-A82B2800-5B75-4308-B6AE-948ACA6E6304 @default.
- Q80242335 P2093 Q80242335-B2D46F42-4D80-49A1-A91B-6B6FA11A18FE @default.
- Q80242335 P2093 Q80242335-DCE02CAF-F166-4438-A47E-9048B20AAC4C @default.
- Q80242335 P2093 Q80242335-DE81EA60-305B-4BF7-8F2C-F3838E9894C1 @default.
- Q80242335 P2093 Q80242335-EC406A13-0235-4F08-B622-64097F1B8650 @default.
- Q80242335 P2093 Q80242335-F7B12BAF-DABB-4835-892E-7428D36FDCC6 @default.
- Q80242335 P304 Q80242335-B804E915-C6B9-492E-8C3C-CF0EC56245DA @default.
- Q80242335 P31 Q80242335-33B15075-F293-4AB5-AEFC-3A4D9A00859D @default.
- Q80242335 P356 Q80242335-8630414B-BDA6-40B7-A794-DDE7C45FD9F1 @default.
- Q80242335 P407 Q80242335-E8A01AE0-3760-4C7C-8549-F5DB207D1246 @default.
- Q80242335 P433 Q80242335-C5FD60A7-BC5D-4C95-A2E7-336DDAEBC23E @default.
- Q80242335 P478 Q80242335-E4547856-6EDA-4504-91C0-61A45A28D027 @default.
- Q80242335 P50 Q80242335-D4629060-F119-4E00-B67A-FC45C54A8EE2 @default.
- Q80242335 P50 Q80242335-FE1DC9CC-5A56-45A5-BD8E-B78B1136123B @default.
- Q80242335 P577 Q80242335-9F2C2385-EE85-4DDE-97D5-CB0ECF6DC327 @default.
- Q80242335 P698 Q80242335-80D6FD77-884E-4FEF-8D60-0D7D25333F13 @default.
- Q80242335 P921 Q80242335-4960760A-870F-45A7-B05B-576447AB485D @default.
- Q80242335 P921 Q80242335-B14EFD3E-E7BC-4777-99B6-36A3475079BB @default.
- Q80242335 P356 J.IJROBP.2006.07.008 @default.
- Q80242335 P698 16965868 @default.
- Q80242335 P1433 Q2296252 @default.
- Q80242335 P1476 "Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer" @default.
- Q80242335 P2093 "Angels Ginès" @default.
- Q80242335 P2093 "Carlos Conill" @default.
- Q80242335 P2093 "Cristina Nadal" @default.
- Q80242335 P2093 "Joan Maurel" @default.
- Q80242335 P2093 "Josep Maria Augé" @default.
- Q80242335 P2093 "Laureano Fernández-Cruz" @default.
- Q80242335 P2093 "Lourdes Petriz" @default.
- Q80242335 P2093 "Marcelo Sánchez" @default.
- Q80242335 P2093 "Maribel Marmol" @default.
- Q80242335 P2093 "Marta Martin-Richard" @default.
- Q80242335 P2093 "Pere Gascón" @default.
- Q80242335 P2093 "Rosa Gallego" @default.
- Q80242335 P2093 "Rosa Miquel" @default.
- Q80242335 P2093 "Rosana Cajal" @default.
- Q80242335 P2093 "Salvador Navarro" @default.
- Q80242335 P304 "1391-1398" @default.
- Q80242335 P31 Q13442814 @default.
- Q80242335 P356 "10.1016/J.IJROBP.2006.07.008" @default.
- Q80242335 P407 Q1860 @default.
- Q80242335 P433 "5" @default.
- Q80242335 P478 "66" @default.
- Q80242335 P50 Q43117839 @default.
- Q80242335 P50 Q91822902 @default.
- Q80242335 P577 "2006-09-11T00:00:00Z" @default.
- Q80242335 P698 "16965868" @default.
- Q80242335 P921 Q212961 @default.
- Q80242335 P921 Q5452194 @default.